Clinical Trial Update: Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating venetoclax to promote apoptosis of HIV-infected cells and reduce the HIV reservoir in people living with HIV on ART. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: University of Aarhus | Conditions: HIV-1-infection | Phase 1, Phase 2 | Status: RECRUITING